---
title: Várri Supports EndCancer.Life in Advancing Oncology Innovation
description: Várri Consultancy supports EndCancer.Life, bringing oncology startups, investors, corporate leaders, and mentors together to advance cancer innovation.
---

[Insights](https://varri.com/insights)

# [Várri Supports EndCancer.Life in Advancing Oncology Innovation](https://varri.com/insights/varri-supports-endcancer-life-oncology-innovation)

 Written by [Johnny Kollin](https://varri.com/insights/author/johnny-kollin) | 18 November 2026, 10:15:34 Z

Few of us will go through life untouched by cancer. [One in five people worldwide develops cancer](https://www.iarc.who.int/cancer-topics/) during their lifetime. Behind that statistic are patients, families, friends, and caregivers.

Frontline professionals work every day to prevent cancer, care for patients, and improve outcomes. Often less visibly, scientists, clinicians, entrepreneurs, investors, and businesses are developing new approaches to cancer prevention, prediction, diagnosis, and treatment.

Turning a promising idea into a sustainable business, however, requires more than scientific or technological progress. Oncology companies must also navigate complex questions of funding, regulation, market adoption, commercial strategy, and organisational development. As these businesses mature, their founders face consequential decisions about capital, partnerships, governance, capabilities, and execution.

At Várri Consultancy, our work frequently sits at the intersection of strategy, risk, governance, investment, and transformation. These disciplines become increasingly important as organisations move from an initial proposition to a more mature, investable business. Our broader commitment to responsible business conduct and continuous improvement is also reflected in [our participation in the UN Global Compact](https://varri.com/insights/varri-consultancy-joins-the-un-global-compact) and our [2026 Communication on Progress](https://varri.com/insights/varri-consultancy-publishes-2026-un-global-compact-communication-on-progress).

External expertise cannot replace robust evidence, strong management, or sound judgement. It can, however, bring a fresh perspective to important decisions, challenge assumptions, and help management identify risks and opportunities earlier.

This is why Várri Consultancy is pleased to support EndCancer.Life, a community focused exclusively on cancer prevention, prediction, diagnostics, and treatment. EndCancer.Life brings together oncology startups and scaleups with investors, corporate leaders, mentors, and other specialists. It aims to give promising companies greater access to relevant expertise, relationships, and capital. Várri Managing Director Johnny Kollin is also participating in EndCancer.Life as a mentor.

## An opportunity for oncology startups and scaleups

EndCancer.Life is currently inviting oncology companies to apply for its [Winter Pitch Competition 2027](https://www.endcancer.life/competition?utm_source=varri&utm_medium=referral&utm_campaign=endcancer_partnership_2027&utm_content=participant_cta). The competition is open to startups and scaleups working in cancer prevention, prediction, diagnostics, and treatment. Five startups and five scaleups will be selected in separate categories to pitch live to investors and corporate leaders.

Interested companies may [apply free of charge on the EndCancer.Life platform](https://www.endcancer.life/register/innovator?utm_source=varri&utm_medium=referral&utm_campaign=endcancer_partnership_2027&utm_content=registerparticipant_cta) and submit a pitch video of up to three minutes. Applications close on 13 December 2026, although the application window may close earlier once 100 startups have applied. A curated group of mentors will review the applications, with finalists expected to be announced in late January. The online pitch competition will take place on 10 February 2027.

Approved companies will also be listed on the EndCancer.Life platform, where they can be discovered by investors and mentors. This may create additional opportunities for conversations and relationships that may extend beyond the competition itself.

## For investors and corporate leaders

EndCancer.Life is also inviting [investors and corporate leaders to participate in the Winter Pitch Competition](https://www.endcancer.life/investors?utm_source=varri&utm_medium=referral&utm_campaign=endcancer_partnership_2027&utm_content=investor_cta). The event provides a focused opportunity to review emerging companies across different areas of oncology and hear directly from their founders.

Registered investors and corporate participants will receive the company catalogue before the event and can ask finalists questions during the live pitches. For investors, this provides an opportunity to identify businesses and technologies that may merit further investigation. For corporate participants, it offers insight into emerging technologies and business models, as well as an opportunity to engage with founders and explore potential commercial or strategic relationships.

Participation does not replace appropriate commercial, technical, regulatory, or investment due diligence.

## Mentoring oncology founders

EndCancer.Life is also building a community of mentors who can bring relevant experience and perspective to participating companies. Mentors may help select the startups that will pitch and, depending on each participating company’s needs and stage of development, may also help founders test assumptions, consider strategic options, identify emerging risks, and prepare for conversations with investors and potential partners.

Executives, entrepreneurs, investors, operators, and specialists with relevant experience can [explore opportunities to contribute through EndCancer.Life](https://www.endcancer.life/mentors?utm_source=varri&utm_medium=referral&utm_campaign=endcancer_partnership_2027&utm_content=mentor_cta).

[View full post](https://varri.com/insights/varri-supports-endcancer-life-oncology-innovation)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Johnny Kollin"
  },
  "dateModified" : "2026-11-18T10:15:42.992Z",
  "datePublished" : "2026-11-18T10:15:34Z",
  "headline" : "Várri Supports EndCancer.Life in Advancing Oncology Innovation",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1260,
    "url" : "https://8948408.fs1.hubspotusercontent-eu1.net/hubfs/8948408/company-assets/blog/varri-oncology-innovation.png",
    "width" : 2400
  },
  "mainEntityOfPage" : "https://varri.com/insights/varri-supports-endcancer-life-oncology-innovation",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://8948408.fs1.hubspotusercontent-na1.net/hubfs/8948408/logos/Varri-primary-logo-trans-600w.png",
      "width" : 92.07161
    },
    "name" : "Insights"
  }
}
```